Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease
- PMID: 18305068
- DOI: 10.1136/gut.2007.142588
Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease
Abstract
Background and aims: Reduced ileal Paneth cell alpha-defensin expression has been reported to be associated with Crohn's disease, especially in patients carrying NOD2 mutations. The aim of this study was to independently assess whether NOD2, alpha-defensins and Crohn's disease are linked.
Methods: Using quantitative real-time polymerase chain reaction (RT-PCR), we measured the mRNA expression levels of key Paneth cell antimicrobial peptides (DEFA5, DEFA6, LYZ, PLA2G2A), inflammatory cytokines [interkelukin 6 (IL6) and IL8], and a marker of epithelial cell content, villin (VIL1) in 106 samples from both affected ileum (inflamed Crohn's disease cases, n = 44) and unaffected ileum (non-inflamed; Crohn's disease cases, n = 51 and controls, n = 11). Anti-human defensin 5 (HD-5) and haematoxylin/eosin immunohistochemical staining was performed on parallel sections from NOD2 wild-type and NOD2 mutant ileal Crohn's disease tissue.
Results: In Crohn's disease patients, DEFA5 and DEFA6 mRNA expression levels were 1.9- and 2.2-fold lower, respectively, in histologically confirmed inflamed ileal mucosa after adjustment for confounders (DEFA5, p<0.001; DEFA6, p = 0.001). In contrast to previous studies, we found no significant association between alpha-defensin expression and NOD2 genotype. HD-5 protein data supports these RNA findings. The reduction in HD-5 protein expression appears due to surface epithelial cell loss and reduced Paneth cell numbers as a consequence of tissue damage.
Conclusions: Reduction in alpha-defensin expression is independent of NOD2 status and is due to loss of surface epithelium as a consequence of inflammatory changes rather than being the inciting event prior to inflammation in ileal Crohn's disease.
Comment in
-
Decreased Paneth cell defensin expression in ileal Crohn's disease is independent of inflammation, but linked to the NOD2 1007fs genotype.Gut. 2009 Jun;58(6):882-3; discussion 883-4. Gut. 2009. PMID: 19433600 No abstract available.
-
Controversy over NOD2, inflammation, and defensins.Inflamm Bowel Dis. 2010 Nov;16(11):1996-8. doi: 10.1002/ibd.21213. Inflamm Bowel Dis. 2010. PMID: 20128000 Free PMC article.
Similar articles
-
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.Gut. 2004 Nov;53(11):1658-64. doi: 10.1136/gut.2003.032805. Gut. 2004. PMID: 15479689 Free PMC article.
-
Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.J Leukoc Biol. 2005 Apr;77(4):460-5. doi: 10.1189/jlb.0904543. Epub 2004 Dec 23. J Leukoc Biol. 2005. PMID: 15618294 Review.
-
Defensins and inflammation: the role of defensins in inflammatory bowel disease.J Gastroenterol Hepatol. 2009 Feb;24(2):202-8. doi: 10.1111/j.1440-1746.2008.05772.x. J Gastroenterol Hepatol. 2009. PMID: 19215333 Review.
-
Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues.FEBS Lett. 2006 Oct 2;580(22):5344-50. doi: 10.1016/j.febslet.2006.08.083. Epub 2006 Sep 12. FEBS Lett. 2006. PMID: 16989824
-
Defensin-immunology in inflammatory bowel disease.Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S137-44. doi: 10.1016/S0399-8320(09)73149-5. Gastroenterol Clin Biol. 2009. PMID: 20117337
Cited by
-
NOD2-mediated dual negative regulation of inflammatory responses triggered by TLRs in the gastrointestinal tract.Front Immunol. 2024 Sep 30;15:1433620. doi: 10.3389/fimmu.2024.1433620. eCollection 2024. Front Immunol. 2024. PMID: 39403381 Free PMC article. Review.
-
Azathioprine promotes intestinal epithelial cell differentiation into Paneth cells and alleviates ileal Crohn's disease severity.Sci Rep. 2024 Jun 5;14(1):12879. doi: 10.1038/s41598-024-63730-4. Sci Rep. 2024. PMID: 38839896 Free PMC article.
-
Role and molecular mechanism of NOD2 in chronic non-communicable diseases.J Mol Med (Berl). 2024 Jun;102(6):787-799. doi: 10.1007/s00109-024-02451-7. Epub 2024 May 14. J Mol Med (Berl). 2024. PMID: 38740600 Review.
-
The epithelium takes the stage in asthma and inflammatory bowel diseases.Front Cell Dev Biol. 2024 Mar 11;12:1258859. doi: 10.3389/fcell.2024.1258859. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38529406 Free PMC article. Review.
-
Evaluation of oxidative stress in an experimental model of Crohn's disease treated with hyperbaric oxygen therapy.Clinics (Sao Paulo). 2023 Nov 15;78:100305. doi: 10.1016/j.clinsp.2023.100305. eCollection 2023. Clinics (Sao Paulo). 2023. PMID: 37976650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical